Prof Stephan Baldus (University of Koln Medical Center, Koln, DE) discusses the JenaValve™ TAVI System - 30-day outcomes from an early feasibility study to assess the safety and effectiveness of the JenaValve™ for symptomatic severe aortic regurgitation.

Filmed on site at EuroPCR 2019 by Radcliffe Cardiology

Questions:

1. Can you describe the novel valve delivery system tested in this study?

2. What is the rationale for this study and what is the design and associated endpoints?

3. What were your findings?

4. What conclusions can be made as a result of this initial data?

5. How long do you plan to follow these patients?

Videography: Mike Knight

Interviewer: Liam O'Neill